Regulatory Affairs & Pharmacovigilance Intern

Are you passionate about regulatory compliance and patient safety? Do you want to gain hands-on experience in ensuring medicines are safe and effective for patients worldwide? If so, we have an exciting opportunity for you as a Regulatory Affairs & Pharmacovigilance Intern at Novo Nordisk! Read on and apply today.

Your new role

As the Regulatory Affairs & Pharmacovigilance Intern in Novo Nordisk Malaysia, you will work on smaller projects and daily operational tasks under one of the sub-departments. You will play a role in assisting the sub-department to achieve its goal by simplifying internal processes and to drive efficiency for others.  This internship opportunity will give you the opportunity to develop skillsets that will be beneficial to your future career growth, such as Microsoft Office, project management, communication and working with others. Other responsibilities include but are not limited to:

• Perform daily pharmacovigilance checking on mailboxes for solicited and spontaneous AE/ADR cases and register the cases.
• Perform daily checking on the follow up cases received from GPS, local and international Medical Device cases, and CIOMS report and process them accordingly. 

• Ensure internal PV tracker is being updated daily or/when there is any update in the information.
• Internship duration: minimum 6 months
• Working hours: Mondays to Fridays, 9am – 6pm (inclusive of lunch hour)
• Location: KL Sentral
• Internship allowance is given

Your new department

This role is part of the Medical and Regulatory (MR) Department at Novo Nordisk Malaysia. The department is responsible for ensuring regulatory compliance for new products and product amendments, safeguarding patients, and ensuring medicines are safe to use. The team works on regulatory approvals, safety data analysis, and shaping future regulatory frameworks through collaboration with health authorities and policymakers. Together, we contribute to improving the lives of millions of people living with serious chronic diseases in Malaysia, where nearly 1 in 5 adults are diagnosed with diabetes. The atmosphere is collaborative, dynamic, and driven by a shared purpose to make a difference.

Your skills & qualifications

To be successful in this role, we are looking for a candidate who possesses these qualifications:

• Undergraduates/graduates with bachelor’s or master’s degree in any science field or relevant field of study.
• A proactive mindset with a can-do attitude.
• Fluent in oral and written English.
• A keen interest in regulatory affairs and pharmacovigilance.
• Proficiency in Microsoft Excel and Outlook (guidance on internal systems will be provided).

Working at Novo Nordisk
Every day we seek the solutions that defeat serious chronic diseases. To do this, we approach our work with an unconventional spirit, a rare determination and a constant curiosity. For over 100 years this unordinary mindset has seen us build a company unlike any other. One where a collective passion for our purpose, mutual respect and a willingness to go beyond what we know delivers extraordinary results.

Deadline
3 August 2026. Applications are reviewed on an ongoing basis. The position may be closed before the deadline.

We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

At Novo Nordisk, we're not chasing quick fixes – we're creating lasting change for long-term health. For over 100 years, we've been driven by a single purpose: to defeat serious chronic diseases and help millions of people live healthier lives. This dedication fuels our constant curiosity and inspires us to push the boundaries of what's possible in healthcare. We embrace diverse perspectives, seek out bold ideas, and build partnerships rooted in shared purpose. Together, we're making healthcare more accessible, treating and preventing diseases, and pioneering solutions that create change spanning generations. When you join us, you become part of something bigger – a legacy of impact that reaches far beyond today.